Endonovo Therapeutics Issues Shareholder Update
October 12, 2021 16:05 ET
|
Endonovo Therapeutics, Inc.
High-Growth Acquisition Approaches Completion, Expected To Augment Core Business And Drive Long-Term Shareholder Value Los Angeles, CA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc....